BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34027242)

  • 1. A National Survey of Practice Patterns for Accepting Living Kidney Donors With Prior COVID-19.
    Jan MY; Jawed AT; Barros N; Adebiyi O; Diez A; Fridell JA; Goggins WC; Yaqub MS; Anderson MD; Mujtaba MA; Taber TE; Mishler DP; Kumar V; Lentine KL; Sharfuddin AA
    Kidney Int Rep; 2021 Aug; 6(8):2066-2074. PubMed ID: 34027242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why Living Kidney Donor Candidates Are Turned Down? A Single-Center Cohort Study.
    Altheaby A; Almukhlifi A; Aldoukhi A; Alfaleh A; Aboalsamah G; Alshareef A; Alruwaymi M; Bin Saad K; Arabi Z
    Cureus; 2020 Aug; 12(8):e9877. PubMed ID: 32963917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein L1 Opinions of African American Living Kidney Donors, Kidney Transplant Patients, and Nonpatients.
    Harris DD; Fleishman A; Pavlakis M; Pollak MR; Baliga PK; Rohan V; Kayler LK; Rodrigue JR
    J Surg Res; 2022 Sep; 277():116-124. PubMed ID: 35489216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An International survey on living kidney donation and transplant practices during the COVID-19 pandemic.
    Salvalaggio PR; Ferreira GF; Caliskan Y; Vest LS; Schnitzler MA; de Sandes-Freitas TV; Moura LR; Lam NN; Maldonado RA; Loupy A; Axelrod DA; Lentine KL
    Transpl Infect Dis; 2021 Apr; 23(2):e13526. PubMed ID: 33245844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing the Costs of Routine Follow-up Care After Living Kidney Donation: a Review and Survey of Contemporary Experience, Practices, and Challenges.
    Lentine KL; Sarabu N; McNatt G; Howey R; Hays R; Thomas CP; Lebron-Banks U; Ohler L; Wooley C; Wisniewski A; Xiao H; Tietjen A
    Curr Transplant Rep; 2022; 9(4):328-335. PubMed ID: 36187071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of the mKidney mHealth System on Live Donor Follow-Up Compliance: Protocol for a Randomized Controlled Trial.
    Henderson ML; Thomas AG; Eno AK; Waldram MM; Bannon J; Massie AB; Levan MA; Segev DL; Bingaman AW
    JMIR Res Protoc; 2019 Jan; 8(1):e11000. PubMed ID: 30664485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interviews of living kidney donors to assess donation-related concerns and information-gathering practices.
    Ruck JM; Van Pilsum Rasmussen SE; Henderson ML; Massie AB; Segev DL
    BMC Nephrol; 2018 Jun; 19(1):130. PubMed ID: 29884126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient Perspectives on Weight Management for Living Kidney Donation.
    Mustian MN; Hanaway M; Kumar V; Reed RD; Shelton BA; Grant R; Carter A; Locke JE
    J Surg Res; 2019 Dec; 244():50-56. PubMed ID: 31279263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Living-Donor Kidney Transplantation: Reducing Financial Barriers to Live Kidney Donation--Recommendations from a Consensus Conference.
    Tushla L; Rudow DL; Milton J; Rodrigue JR; Schold JD; Hays R;
    Clin J Am Soc Nephrol; 2015 Sep; 10(9):1696-702. PubMed ID: 26002904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Living-donor follow-up attitudes and practices in U.S. kidney and liver donor programs.
    Waterman AD; Dew MA; Davis CL; McCabe M; Wainright JL; Forland CL; Bolton L; Cooper M
    Transplantation; 2013 Mar; 95(6):883-8. PubMed ID: 23388736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of US Living Kidney Donation and Transplantation Practices in the COVID-19 Era.
    Lentine KL; Vest LS; Schnitzler MA; Mannon RB; Kumar V; Doshi MD; Cooper M; Mandelbrot DA; Harhay MN; Josephson MA; Caliskan Y; Sharfuddin A; Kasiske BL; Axelrod DA
    Kidney Int Rep; 2020 Nov; 5(11):1894-1905. PubMed ID: 32864513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes-free survival among living kidney donors and non-donors with obesity: A longitudinal cohort study.
    Killian AC; Reed RD; McLeod MC; MacLennan PA; Kumar V; Pittman SE; Maynor AG; Stanford LA; Baker GA; Schinstock CA; Silkensen JR; Roll GR; Segev DL; Orandi BJ; Lewis CE; Locke JE
    PLoS One; 2022; 17(11):e0276882. PubMed ID: 36399462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Living kidney donor informed consent practices vary between US and non-US centers.
    Parekh AM; Gordon EJ; Garg AX; Waterman AD; Kulkarni S; Parikh CR
    Nephrol Dial Transplant; 2008 Oct; 23(10):3316-24. PubMed ID: 18599559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why Potential Living Kidney Donors Do Not Proceed for Donation: A Single-Center Experience.
    AlBugami MM; AlOtaibe FE; Boqari D; AlAbadi AM; Hamawi K; Bel'eed-Akkari K
    Transplant Proc; 2019 Mar; 51(2):504-508. PubMed ID: 30879577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitude of kidney patients on the transplant waiting list toward related-living donation. A reason for the scarce development of living donation in Spain.
    Martínez-Alarcón L; Ríos A; Conesa C; Alcaraz J; González MJ; Ramírez P; Parrilla P
    Clin Transplant; 2006; 20(6):719-24. PubMed ID: 17100721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying Risk Tolerance Among Potential Living Kidney Donors With the Donor-Specific Risk Questionnaire.
    Thiessen C; Gannon J; Li S; Skrip L; Dobosz D; Gan G; Deng Y; Kennedy K; Gray D; Mussell A; Reese PP; Gordon EJ; Kulkarni S
    Am J Kidney Dis; 2021 Aug; 78(2):246-258. PubMed ID: 33508397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of living kidney donors and adherence to national live donor guidelines in the UK.
    Arunachalam C; Garrues M; Biggins F; Woywodt A; Ahmed A
    Nephrol Dial Transplant; 2013 Jul; 28(7):1952-60. PubMed ID: 23658249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethnic and gender related differences in the risk of end-stage renal disease after living kidney donation.
    Cherikh WS; Young CJ; Kramer BF; Taranto SE; Randall HB; Fan PY
    Am J Transplant; 2011 Aug; 11(8):1650-5. PubMed ID: 21672160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the Attitudes and Perceptions Regarding the Use of Mobile Health Technologies for Living Kidney Donor Follow-Up: Survey Study.
    Eno AK; Thomas AG; Ruck JM; Van Pilsum Rasmussen SE; Halpern SE; Waldram MM; Muzaale AD; Purnell TS; Massie AB; Garonzik Wang JM; Lentine KL; Segev DL; Henderson ML
    JMIR Mhealth Uhealth; 2018 Oct; 6(10):e11192. PubMed ID: 30305260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Financial incentives versus standard of care to improve patient compliance with live kidney donor follow-up: protocol for a multi-center, parallel-group randomized controlled trial.
    Levan ML; Waldram MM; DiBrito SR; Thomas AG; Al Ammary F; Ottman S; Bannon J; Brennan DC; Massie AB; Scalea J; Barth RN; Segev DL; Garonzik-Wang JM
    BMC Nephrol; 2020 Nov; 21(1):465. PubMed ID: 33167882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.